Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rubicon Medical was a medical device company specializing in the design and development of interventional cardiology and radiology products. The company's flagship technology was a proprietary embolic protection filter used to capture debris during vascular procedures, such as stenting, to prevent complications like stroke. This low-profile filter was designed to be easily delivered and retrieved within the vasculature. In 2005, Rubicon Medical was acquired by Boston Scientific for approximately $70 million. The acquisition allowed Boston Scientific to integrate Rubicon's filter technology into its broader portfolio of cardiovascular intervention tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rubicon Medical.